Novartis gains rights to Arvinas’ prostate cancer therapy in deal worth over $1bn

1 year ago 58
Glucoberry Blood Sugar Supplement


The transaction also includes the sale of Arvinas’ preclinical AR-V7 programme
Read Entire Article
  1. Homepage
  2. Prostate Cancer
  3. Novartis gains rights to Arvinas’ prostate cancer therapy in deal worth over $1bn

Related

Pedro Barata, MD, on darolutamide efficacy across age subgroups

Pedro Barata, MD, on darolutamide efficacy across age subgro...

1 month ago 58
NHS could offer a prostate cancer diagnosis within a day using AI

NHS could offer a prostate cancer diagnosis within a day usi...

1 month ago 48
Daiichi Sankyo’s Latest Clinical Trial: A Potential Game-Changer for Prostate Cancer Treatment

Daiichi Sankyo’s Latest Clinical Trial: A Potential Game-Cha...

1 month ago 50
Neuro-Thrive Supplement




Trending

1. Bob Dylan
2. Barge
3. Whale capsizes boat
4. Argentina vs Morocco
5. Tesla stock
6. Jimmy Carter
7. Michael Gallup
8. John Mayall
9. Bob Newhart
10. Yellowstone

Popular

Darwin woman forced to fly interstate for a cancer diagnosis, but the NT government denies there's a problem

Darwin woman forced to fly interstate for a cancer diagnosis...

2 years ago 297
Reduce your risk of cancer: get involved and have fun

Reduce your risk of cancer: get involved and have fun

2 years ago 266
Stone Roses legend’s wife dead aged 52 after long cancer battle

Stone Roses legend’s wife dead aged 52 after long cancer bat...

2 years ago 255
Former OU 2-sport standout Ryan Minor has no more treatment options available for stage 4 colon cancer

Former OU 2-sport standout Ryan Minor has no more treatment ...

2 years ago 246
B.C. woman raises awareness of pancreatic cancer after husband, son die 55 days apart

B.C. woman raises awareness of pancreatic cancer after husba...

2 years ago 244
Biodynamics Supplement


English (US) English (US) ·
About Us · Contact Us · Terms & Conditions ·

Copyright © 2019 - 2025 | Whatiscancer.net | All Rights Reserved.